These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35984314)

  • 1. The complex interplay between diabetes mellitus and atrial fibrillation.
    Yildiz M; Lavie CJ; Morin DP; Oktay AA
    Expert Rev Cardiovasc Ther; 2022 Sep; 20(9):707-717. PubMed ID: 35984314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus.
    Moss AS; Dimitropoulos G; Connolly DL; Lip GYH
    Expert Opin Pharmacother; 2017 Aug; 18(11):1101-1114. PubMed ID: 28669216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus.
    Fauchier L; Boriani G; de Groot JR; Kreutz R; Rossing P; Camm AJ
    Europace; 2021 Dec; 23(12):1873-1891. PubMed ID: 34411235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atrial Fibrillation and Diabetes Mellitus: the Control of Thromboembolic Risk].
    Obrezan AG; Kulikov NV
    Kardiologiia; 2020 Aug; 60(7):108-114. PubMed ID: 33155949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial Fibrillation, Type 2 Diabetes, and Non-Vitamin K Antagonist Oral Anticoagulants: A Review.
    Plitt A; McGuire DK; Giugliano RP
    JAMA Cardiol; 2017 Apr; 2(4):442-448. PubMed ID: 28122078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry.
    Domek M; Gumprecht J; Li YG; Proietti M; Rashed W; Al Qudaimi A; Gumprecht J; Zubaid M; Lip GYH
    Eur J Clin Invest; 2021 Mar; 51(3):e13385. PubMed ID: 32810282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy.
    Staszewsky L; Cortesi L; Baviera M; Tettamanti M; Marzona I; Nobili A; Fortino I; Bortolotti A; Merlino L; Disertori M; Latini R; Roncaglioni MC
    Diabetes Res Clin Pract; 2015 Sep; 109(3):476-84. PubMed ID: 26220013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The connubium among diabetes, chronic kidney disease and atrial fibrillation.
    Magnocavallo M; Vetta G; Trivigno S; Mariani MV; DI Lullo L; Bellasi A; Della Rocca DG; Severino P; Piro A; Giunta G; Quaglione R; Lavalle C
    Minerva Cardiol Angiol; 2022 Jun; 70(3):393-402. PubMed ID: 35212508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).
    Fatemi O; Yuriditsky E; Tsioufis C; Tsachris D; Morgan T; Basile J; Bigger T; Cushman W; Goff D; Soliman EZ; Thomas A; Papademetriou V
    Am J Cardiol; 2014 Oct; 114(8):1217-22. PubMed ID: 25159234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the presence of diabetes mellitus confer an increased risk of stroke in patients with atrial fibrillation on direct oral anticoagulants? A systematic review and meta-analysis.
    Abdool M; Kunutsor SK; Khunti K; Seidu S
    Diabetes Metab Syndr; 2020; 14(6):1725-1733. PubMed ID: 32916556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants: meta-analysis of eight outcomes in 58 634 patients across four randomized controlled trials.
    Plitt A; Zelniker TA; Park JG; McGuire DK; Ruff CT; Antman EM; Braunwald E; Giugliano RP
    Eur Heart J Cardiovasc Pharmacother; 2021 Apr; 7(FI1):f40-f49. PubMed ID: 33063112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry.
    García-Fernández A; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Ruiz Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Otero D; Anguita M; Lip GYH; Marín F;
    Ann Med; 2020 Sep; 52(6):300-309. PubMed ID: 32500748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study.
    Gumprecht J; Lip GYH; Sokal A; Średniawa B; Mitręga K; Stokwiszewski J; Wierucki Ł; Rajca A; Rutkowski M; Zdrojewski T; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z
    Cardiovasc Diabetol; 2021 Jun; 20(1):128. PubMed ID: 34167520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetes mellitus and atrial fibrillation: evidence of a pathophysiological, clinical and epidemiological association beyond the thromboembolic risk].
    Proietti R; Russo V; Wu MA; Maggioni AP; Marfella R
    G Ital Cardiol (Rome); 2017 Mar; 18(3):199-207. PubMed ID: 28398378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report.
    Fumagalli S; Said SA; Laroche C; Gabbai D; Boni S; Marchionni N; Boriani G; Maggioni AP; Musialik-Lydka A; Sokal A; Petersen J; Crijns HJGM; Lip GYH;
    Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):172-179. PubMed ID: 29309557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.
    Echouffo-Tcheugui JB; Shrader P; Thomas L; Gersh BJ; Kowey PR; Mahaffey KW; Singer DE; Hylek EM; Go AS; Peterson ED; Piccini JP; Fonarow GC
    J Am Coll Cardiol; 2017 Sep; 70(11):1325-1335. PubMed ID: 28882229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated care and outcomes in patients with atrial fibrillation and comorbidities.
    Proietti M; Vitolo M; Lip GYH
    Eur J Clin Invest; 2021 Jun; 51(6):e13498. PubMed ID: 33482011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial).
    Aksnes TA; Schmieder RE; Kjeldsen SE; Ghani S; Hua TA; Julius S
    Am J Cardiol; 2008 Mar; 101(5):634-8. PubMed ID: 18308012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data Linking Diabetes Mellitus and Atrial Fibrillation-How Strong Is the Evidence? From Epidemiology and Pathophysiology to Therapeutic Implications.
    Şerban RC; Scridon A
    Can J Cardiol; 2018 Nov; 34(11):1492-1502. PubMed ID: 30404752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation.
    Papazoglou AS; Kartas A; Moysidis DV; Tsagkaris C; Papadakos SP; Bekiaridou A; Samaras A; Karagiannidis E; Papadakis M; Giannakoulas G
    Cardiovasc Diabetol; 2022 Mar; 21(1):39. PubMed ID: 35287684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.